VAB's YourHealth Community


 
contents
Imagine Your Health®
 
cover story
past cover stories
features
eye surgery
plastic surgery
fertility
ear, nose, & throat
eye care
cosmetic dentistry
dermatology
orthodontics
health & fitness
nutrition
fitness
readers' choice
entertainment
quiz yourself
on the street
he said, she said
letters to the editor
ask dr. carolle
article
q & a
editor's introduction
education & awards
publications
about dr. carolle
future articles
health care news
read the latest
updates from the FDA
meet the staff
the minds behind the mag
We value your opinion. Please use the contact link in the bottom right corner of our site to provide your feedback. Thanks.

home > health care news > in the news
 
 print article
send to a friend
comments?


New Implanted Device Sends Vibrations to the Brain to Help Hearing Impaired


A first-of-its-kind hearing device has been approved that sends vibrations to the brain rather than simply magnifying sound like traditional hearing aids. The surgically implanted device is for adults with moderate to severe nerve hearing loss, not for the profoundly deaf.

Implanted in the skull bone behind the ear, the Vibrant Soundbridge device converts sound into mechanical energy and transfers the energy to the wearer's middle ear via a wire. The energy vibrates delicate structures in the middle ear in much the same way that sound normally would, allowing the brain to interpret the vibrations as sound.

In clinical studies, the Vibrant Soundbridge was shown to improve hearing about as much as conventional hearing aids. On the plus side, the new device was less visible than some standard hearing aids, and it wasn't hampered by earwax and moisture, which can be problematic with conventional devices.

But the surgery to implant the Vibrant Soundbridge entails the usual risks from surgical procedures, including infections and anesthesia risks. Other complications reported by patients in clinical studies included worsened hearing (2 percent), permanently altered taste (2 percent), long-term pain in the ear (5 percent), and a permanent feeling of "fullness" in the ear (16 percent).

FDA approved the implant in August based on a U.S. study of 81 patients, supporting data from European studies, and the recommendation of an FDA advisory committee. The device's manufacturer, Symphonix Devices Inc., San Jose, Calif., is doing an 18-month follow-up study to determine the implant's long-term safety and effectiveness.

Imagine YourHealth - Look Better, Feel Better, Live Longer
ENTER YOUR ZIP CODE
Sponsors
-----------------


-----------------

 

 

 
home | terms of use | contact us | help  
 
 
Copyright ©2000. Einstein Medical, All rights reserved. This material may not be published, broadcast, rewritten, or redistributed in any form. Use of this site signifies your agreement to the above.